Tag: risk-based validation

Guidance on Validation of Backup Power Systems for Pharmaceutical Stability Testing

Pharmaceutical companies performing stability testing are heavily reliant on uninterrupted environmental conditions. Loss of power—however brief—can lead to temperature or humidity excursions that jeopardize product integrity and result in non-compliance. This makes validation of backup power systems (UPS, diesel generators, etc.) a critical component of the equipment validation process. Why Backup Power Validation Matters Backup…

Equipment and Calibration, Validation of Stability Testing Equipment

Risk-Based Validation Approach for New Stability Chambers

As pharmaceutical companies expand or modernize their stability testing infrastructure, the need to validate new stability chambers becomes inevitable. Traditionally, validation followed a one-size-fits-all model, but today’s regulatory bodies encourage a risk-based validation (RBV) approach—especially for equipment qualification. This tutorial outlines how to implement a compliant, efficient RBV framework for new chambers. What is Risk-Based…

Equipment and Calibration, Validation of Stability Testing Equipment

Equipment Validation in Multi-Site Stability Testing Facilities

In today’s global pharmaceutical operations, stability testing often spans multiple facilities across geographies. Managing equipment validation in such multi-site setups presents unique regulatory, logistical, and documentation challenges. This tutorial offers a step-by-step framework for executing IQ, OQ, and PQ protocols consistently across different sites, while maintaining compliance with global regulatory expectations. Understanding Multi-Site Validation: Why…

Equipment and Calibration, Validation of Stability Testing Equipment

Validating Software Systems Used for Stability Data Handling

In the pharmaceutical industry, software systems play a crucial role in managing, storing, and analyzing stability study data. Validating these systems is not just a regulatory requirement—it’s an essential practice to ensure data integrity, reproducibility, and compliance. This article outlines a comprehensive, risk-based approach to validating software systems used in stability data management. 🔍 Why…

Best Practices for Stability Testing Data Integrity, Pharmaceutical Quality and Practices

Applying ICH Q9 to Risk Management in Stability Protocols

In the realm of pharmaceutical development and regulatory compliance, risk-based thinking is no longer optional—it is expected. The International Conference on Harmonisation’s ICH Q9 guideline provides the framework for applying Quality Risk Management (QRM) across the product lifecycle. In this article, we explore how ICH Q9 principles can and should be integrated into stability testing…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.), Regulatory Guidelines